Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 96 Inflammatory Breast Neoplasms 9 Carcinoma, Intraductal, Noninfiltrating 8 Breast Neoplasms, Male 6 Breast Carcinoma In Situ 6 Neoplasm Metastasis 4 Triple Negative Breast Neoplasms 3 Neoplasms 3 Locally Advanced Breast Cancer 2 Colorectal Neoplasms 2 Breast Cancer Patients 2 Stress, Psychological 1 Postoperative Complications 1 Pathologic Complete Response 1 Neovascularization, Pathologic 1 Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer 1 Motor Activity 1 Margins of Excision 1 Inflammation 1 Infertility 1 High-Risk Cancer 1 Head and Neck Neoplasms 1 HER2-positive Breast Cancer 1 Evaluation of the Value of Mammaprint Test Gene Variation in the Prediction of Neoadjuvant Chemotherapy for Breast Cancer 1 Colonic Neoplasms 1 Cardiotoxicity 1 Carcinoma, Lobular 1 Breast Cancer-specific Survival 1 Breast Cancer Metastatic 1 Breast Cancer Invasive 1

Interventions

Neoadjuvant Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

High-Risk Cancer × Neoadjuvant Therapy × Breast × Clear all

NCT03978663 2026-02-20

TRIO

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Active not recruiting

High-Risk Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡